Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,571 | 22,397 | 22,419 | 27,457 | 28,137 |
| Marketable Securities | 92,358 | 106,823 | 120,159 | 124,531 | 132,935 |
| TOTAL | $120,569 | $131,496 | $145,156 | $153,449 | $165,885 |
| Non-Current Assets | |||||
| PPE Net | 267 | 242 | 330 | 316 | 288 |
| Other Non-Current Assets | 3,557 | 3,563 | 2,170 | 1,919 | 826 |
| TOTAL | $3,824 | $3,805 | $2,500 | $2,235 | $1,114 |
| Total Assets | $124,393 | $135,301 | $147,656 | $155,684 | $166,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,726 | 2,575 | 4,541 | 2,068 | 2,863 |
| Accrued Expenses | 5,538 | 4,822 | 2,785 | 1,341 | 1,647 |
| TOTAL | $10,637 | $7,782 | $7,705 | $3,756 | $4,703 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 661 | 776 | 813 | 875 | 349 |
| TOTAL | $661 | $776 | $813 | $875 | $349 |
| Total Liabilities | $11,298 | $8,558 | $8,518 | $4,631 | $5,052 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 710 | 707 | 701 | 697 | 696 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -104,423 | -87,903 | -72,881 | -59,293 | -47,302 |
| Other shareholders' equity | -201 | -466 | -771 | -785 | -644 |
| TOTAL | $113,095 | $126,743 | $139,138 | $151,053 | $161,947 |
| Total Liabilities And Equity | $124,393 | $135,301 | $147,656 | $155,684 | $166,999 |